News

A taskforce has reviewed published studies on the use of immunomodulatory therapies in the treatment of COVID-19 and has released new points to consider on the use of these drugs.

Researchers have identified how cancer cells become resistant to hormone or combination therapies in patients with early-stage breast cancer.

University of Michigan researchers have found a simple method for identifying nanobodies with drug-like properties suitable for preventing SARS-CoV-2 infections.

A study involving virtual patients was as effective as traditional clinical trials in evaluating a medical device used to treat brain aneurysms.

Geneticists have found a gene that determines eye color in fruit flies and also plays a role in the uncontrolled proliferation of gut stem cells.

Using cell cultures a reserach team has shown that a molecular inhibitor of METTL3 can reduce the replication of SARS-CoV-2 and, a seasonal coronavirus, HCoV-OC43.

A new observational study has begun to evaluate the immune responses generated by COVID-19 vaccines administered to pregnant or postpartum people.

Scientists have developed an antibody conjugate that delivers drugs to bone tumors and inhibits metastasis.

Researchers aim to speed up brain disease drug development through cutting-edge technology. They are generating a technology platform, termed "i3D-Markers".

To identify the chemical composition of different materials, a technique called X-ray photoelectron spectroscopy (XPS) is often used. It has existed since the 1960s and is today a standard method in materials science. But researchers have been able to show that the method often gives incorrect results.